Why does rare disease drug production require an expert small-batch CDMO?

An orphan disease, also known as a rare disease, is a condition affecting a very limited number of patients. In Europe, it is defined as a disease affecting fewer than one in 2,000 people.
These diseases often require specific, scarcely available treatments, necessitating tailored pharmaceutical production in low volumes.